US 8617549
Bispecific nanobodies as a therapeutic for alzheimer's disease
granted A61PA61P25/28
Quick answer
US patent 8617549 (Bispecific nanobodies as a therapeutic for alzheimer's disease) held by ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/28